# Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial

Source: https://onco.cc/trials/nct06563388/  
OnCo record `nct06563388` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial in colorectal cancer, run by Roswell Park Cancer Institute, now recruiting.

## Summary

Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial is a phase 3, randomised interventional study registered as NCT06563388 by Roswell Park Cancer Institute, with a registry enrolment figure of 800 participants, started 2024-09-18 and due to reach its primary completion in 2032-09-18. Interventions recorded: Stereotactic Ablative Radiotherapy; Best Practice. Conditions listed: Oligometastasis; Lung Cancer; Colo-rectal Cancer; Prostate Cancer. Primary outcome: Overall Survival - Trial 1 and 2; Androgen DeprivationTherapy (ADT)-free survival - Trial 3. Colorectal eligibility wording from the registry: "* Trials 1-3: Histologically confirmed lung, prostate or colorectal malignancy with metastatic disease detected on imaging". Sites: United States. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Also known as: ID-COMET
- Tags: ctgov-ingest; colorectal-deep-dive
- Registry id: NCT06563388
- Phase: 3
- Setting: (ID-COMET) A Randomized Phase III Trial of Immediate Versus Six-Month Delayed Comprehensive Treatment of 1-10 Oligometastatic Tumors With or Without Synchronous Primary
- Sponsor: Roswell Park Cancer Institute
- Enrolled: 800

## Sources

- ClinicalTrials.gov NCT06563388: https://clinicaltrials.gov/study/NCT06563388

## Connected records

- cancers: [Rectal cancer](https://onco.cc/cancers/rectal-cancer/)
- technologies: [SBRT / SABR (stereotactic radiotherapy)](https://onco.cc/technologies/sbrt/)
- terms: [Colorectal cancer trials open today (registry snapshot)](https://onco.cc/terms/colorectal-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06563388.json